printable article

Originally published September 23 2014

Did you realize the United States government owns the patent on Ebola?

by Ethan A. Huff, staff writer

(NaturalNews) After we recently broke the news about the U.S. government's patent on the human Ebola virus, many of our readers asked for more information explaining how this could possibly be the case. Well, this article will break down the actual patent for so-called "EboBun," which shortly after being identified back in 2007 was deposited with the U.S. Centers for Disease Control and Prevention (CDC) and claimed by the U.S. government as its own "invention."

If you don't believe it, take a look for yourself:

Here, you will see the actual patent for human Ebola virus as cataloged by Google and stamped with the official publication number "CA 2741523 A1." You will also notice that the patent was filed by six individuals representing the U.S. government, including the Secretary of the Department of Health and Human Services (HHS) and the CDC.

"The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention... on November 26, 2007 and accorded an accession number 200706291," reads the official Deposit Statement for the virus.

"Samples of the stated Deposit Accession No. 200706291 will be made available to approved facilities for thirty years from the date of deposit, and for the lifetime of the patent issuing from, or claiming priority to this application."

'Invented' Ebola virus discovered during prior Ugandan outbreak

For those who may be wondering if this is an open admission by the U.S. government that it actually created the human Ebola virus on purpose, the background section of the patent goes on to explain that it was technically just discovered during an outbreak in Uganda. In late November 2007, just before the virus was deposited with the CDC, multiple cases of hemorrhagic fever were discovered in the Bundibugyo District of Western Uganda that were quickly identified as Ebola.

Those who discovered the virus dubbed it "Ebola Bundibugyo virus," or "EboBun" for short, and quickly claimed it as their own intellectual property by bringing it back to the States and filing it with the CDC. And now, any virus that even resembles this particular strain is regarded as the private property of the U.S. government.

Similar Ebola viruses that are even 70 percent similar are also owned by US government

In the same patent filing, the U.S. government added a special claim for other Ebola viruses with similarities to EboBun, pronouncing ownership over them as well. Any nucleotide sequence with at least a 70 percent identity match, according to the claim, is also regarded as the property of the U.S. government.

What this suggests is that the current strain circulating throughout West Africa may also be a government strain, for which government-owned vaccines are already in the pipeline. From disease to treatment, in other words, the U.S. government holds exclusive ownership over this deadly virus, and fully intends to profit from the pain and suffering of thousands, and potentially millions.

None of this is conspiracy theory or speculation, either -- it is factual knowledge freely available for anyone willing to face the facts. Read the patent for yourself and decide whether or not these Ebola outbreaks are legitimate or just a government propaganda campaign to profit from disease and vaccines.

Learn all these details and more at the FREE online Pandemic Preparedness course at

Sources for this article include:

All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit